Cerus Corporation (CERS)
News
| May 15 | 10 biotech securities will be added to the Nasdaq biotech index on May 21: $CERS $CLDX $FOLD $INFI $JAZZ $OMER $OREX $PCRX $RPTP $TSRX by abubnic |
| May 14 | NASDAQ OMX (NDAQ) Adds 10 Stocks to NASDAQ Biotechnology Index (NBI) Street Insider |
| May 14 | NASDAQ Biotechnology Index - semi-annual changes |
| May 11 | Buy stops $hig 1995 $entg 834 $mig 863 $CERS 366. Many good set-ups out there, waiting for $SPX back above 1382 unfortunately will not work. by Ranger94 |
| May 07 | $CERS filed latest Quarterly Report http://stks.co/3h82 by MarketBrief |
| May 07 | CERUS CORP Files SEC form 10-Q, Quarterly Report |
| May 05 | These Cold Stocks Are Heating Up |
| May 03 | These Cold Stocks Are Heating Up Fool |
| May 02 | Cerus Misses Where It Counts |
| May 01 | Cerus Corp (CERS) Misses Q1 EPS by 8c; Guides Below Street Insider |
| May 01 | Listen to $CERS Q1 2012 earnings call - live at 04:15 PM, ondemand after - http://stks.co/3bsn by earningscast |
| Apr 27 | $CERS http://stks.co/3Y76 Watching closely for a breakout. Attempted 1 and failed. Waiting for another. by jamiemc101 |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Biotechnology
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cerus Corporation is up 18.71% over the last year vs S&P 500 Total Return up 1.18%, Infinity Pharmaceuticals up 81.08%, and Jazz Pharmaceuticals up 62.57%.
- CERS Total Returns
- ^SPXTR Total Returns
- INFI Total Returns
- JAZZ Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these CERS related companies
Pro Strategies Featuring CERS
Did Cerus Corporation make it into our Pro Portfolio Strategies?
CERS Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other CERS Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CERS | 3.49 | -0.06 | -1.69% | 189.19M |
| CERN | 79.01 | -0.36 | -0.45% | 13.41B |
| CNGL | 0.3801 | +0.00 | +0.00% | 14.03M |
| CNET | 0.68 | -0.00 | -0.29% | 15.06M |
| CNC | 37.30 | +1.19 | +3.30% | 1.906B |
| CNBKA | 27.50 | +0.04 | +0.15% | 152.35M |
| CNBC | 10.11 | -0.05 | -0.49% | 165.10M |
| CNAM | 0.50 | -0.01 | -1.86% | 7.62M |
| CNAF | 25.25 | +0.25 | +1.00% | 72.22M |
| CNA | 28.56 | -0.15 | -0.52% | 7.693B |
